Quick Answer
GeneDx Holdings Corp. reported Long-Term Debt of $48.18 million for fiscal year 2025.
GeneDx Holdings Corp. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $48.18M | -7.2% |
| 2024 | $51.91M | -1.5% |
| 2023 | $52.69M | +743.0% |
| 2022 | $6.25M | -43.2% |
| 2021 | $11.00M | +0.0% |
| 2021 | $11.00M | -39.0% |
| 2021 | $18.03M | -2.6% |
| 2021 | $18.50M | -2.5% |
| 2020 | $18.97M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.58M | -0.9% | -0.2% |
| June 30, 2025 | $51.68M | -0.9% | -0.2% |
| March 31, 2025 | $51.79M | -1.0% | -0.2% |
| December 31, 2024 | $51.91M | -1.5% | -0.2% |
| September 30, 2024 | $52.03M | +759.8% | -0.2% |
| June 30, 2024 | $52.16M | +734.6% | -0.3% |
| March 31, 2024 | $52.29M | +736.7% | -0.7% |
| December 31, 2023 | $52.69M | +743.0% | +770.6% |
- GeneDx Holdings Corp. showed a decrease of -7.2% in Long-Term Debt compared to the prior fiscal year.
- Over the 2020–2025 period, GeneDx Holdings Corp.’s long-term debt has grown by 153.9% (from $18.97 million to $48.18 million).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: